This is a clinically-oriented, live and interactive Continuing Medical Education (CME) program, with the goal of having practicing oncologists and other cancer health care providers learn more about the biology and diagnostics of Plasma Cell Disorders, and the latest innovations in treating them.

Target Audience
Hematological oncologists, clinical oncologists, and other cancer healthcare providers, including NPs, PAs, and RNs.

Educational Objectives

• Discuss the basics of and the treatment options for myeloma bone disease.
• Describe the newly-available techniques for diagnostics and treatment monitoring.
• Appraise the potential of novel agents and drug combinations in early clinical trials.
• Better manage the short and long-term side effects of cellular therapies.
• Assess and interpret information about the indication, risks and benefits of novel cellular therapies, and how to obtain guidance regarding any treatment selection.

Accreditation – AMA
Roswell Park Comprehensive Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. Roswell Park designates this live educational activity for a maximum of 3.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information and to register click HERE